438 Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in epidermolysis bullosa patients
Chiou, A., Choi, S., Barriga, M., Dutt-Singkh, Y., Solis, D., Nazaroff, J., Bailey-Healy, I., Li, S., Joing, M., Kwon, P., Tang, J.Volume:
138
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2018.03.445
Date:
May, 2018
File:
PDF, 241 KB
english, 2018